Loading...
XSHE
300396
Market cap516mUSD
Dec 05, Last price  
13.39CNY
1D
0.15%
1Q
-4.08%
Jan 2017
-36.29%
IPO
28.78%
Name

Dirui Industrial Co Ltd

Chart & Performance

D1W1MN
XSHE:300396 chart
P/E
25.73
P/S
3.00
EPS
0.52
Div Yield, %
3.73%
Shrs. gr., 5y
-0.10%
Rev. gr., 5y
3.84%
Revenues
1.22b
-10.67%
175,648,733231,187,389358,055,014413,634,969464,403,761486,472,263567,325,998758,694,233867,690,655933,418,5971,008,790,834937,235,915905,795,0401,220,007,7871,363,320,2401,217,807,735
Net income
142m
-48.50%
18,708,17860,389,01576,310,62484,222,59493,607,824101,358,862108,278,048125,136,152167,392,770197,727,875231,892,235267,071,664209,948,414261,827,947275,589,641141,922,552
CFO
-295m
L
3,863,65213,600,78939,078,52065,416,15284,881,039124,170,678151,978,228213,738,344230,957,557236,304,453291,102,980235,647,142167,412,92740,924,699224,498,855-294,752,320
Dividend
May 21, 20240.5 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Dirui Industrial Co.,Ltd. engages in the research and development, production, and sale of medical inspection products in the People's Republic of China. The company provides medical instruments, diagnostic reagents, test strips, etc. It offers biochemical blood cell, urine, coagulation, chemiluminescence immunoassay, and gynecological secretion analyzers. The company was founded in 1992 and is headquartered in Changchun, the People's Republic of China.
IPO date
Sep 10, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT